STERIS 8-K: Q2 FY2026 results press release furnished as Exhibit 99.1

Rhea-AI Filing Summary

STERIS plc furnished an 8-K to announce it issued a press release with financial results for the quarter ended September 30, 2025, which is its fiscal 2026 second quarter. The press release is attached as Exhibit 99.1.

The information under Item 2.02, including Exhibit 99.1, is being furnished to the SEC, not deemed “filed” under Section 18 of the Exchange Act, and is not incorporated by reference into Securities Act filings.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

0001757898Dublin 2,falseD02 R2962025-11-05353001-38848L2falsefalsefalse00017578982025-11-052025-11-050001757898ste:OrdinarySharesMember2025-11-052025-11-050001757898ste:STETwo700SeniorNotesDue2031MemberMember2025-11-052025-11-050001757898ste:Two700SeniorNotesDue2051MemberMember2025-11-052025-11-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 5, 2025

STERIS plc

(Exact Name of Registrant as Specified in Charter)

Ireland

001-38848

98-1455064

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(IRS Employer Identification No.)

70 Sir John Rogerson's Quay,			Dublin 2,			Ireland			D02 R296
(Address of principal executive offices)

Registrant’s telephone number, including area code: + 353 1 232 2000

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Ordinary Shares, $0.001 par value			STE			New York Stock Exchange
2.700% Senior Notes due 2031			STE/31			New York Stock Exchange
3.750% Senior Notes due 2051			STE/51			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02 Results of Operations and Financial Condition.

On November 5, 2025, STERIS plc (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of this press release is attached hereto as Exhibit 99.1.

The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section. Furthermore, the information contained in this Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.						Description
99.1						Press Release issued by STERIS plc on November 5, 2025 announcing financial results for its fiscal 2026 second quarter ending September 30, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

STERIS plc
By						/s/ J. Adam Zangerle
Name:						J. Adam Zangerle
Title:						Senior Vice President, General Counsel & Company Secretary

Dated: November 5, 2025

FAQ

What did STERIS (STE) report in this 8-K?

STERIS furnished a press release announcing financial results for its fiscal 2026 second quarter ended September 30, 2025, attached as Exhibit 99.1.

What period does STERIS’s press release cover?

The press release covers the quarter ended September 30, 2025 (fiscal 2026 Q2).

Is the STERIS (STE) press release filed or furnished?

It is furnished under Item 2.02 and is not deemed “filed” for purposes of Section 18 of the Exchange Act.

Is the information incorporated by reference into other filings?

No. The furnished information, including Exhibit 99.1, is not incorporated by reference into Securities Act registration statements or other documents.

When was the 8-K dated for STERIS (STE)?

The report is dated November 5, 2025.

What exhibit contains the STERIS Q2 FY2026 results?

Exhibit 99.1 contains the press release announcing the quarterly results.